STAR SPORTS MED (01609) has announced its selection for inclusion as a constituent stock of the Hang Seng Composite Index, following the results of the second-quarter index review released by Hang Seng Indexes Company Limited on August 21, 2026. The inclusion will take effect from September 7, 2026.
Following its inclusion in the Hang Seng Composite Index, the company's shares are expected to meet the eligibility criteria for trading under the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs. The board believes that being selected for the Hang Seng Composite Index marks a significant milestone in the company's capital market development since its listing, which is anticipated to enhance its visibility and investability in the Hong Kong capital market while broadening its potential investor base.
The company remains committed to advancing product innovation in the sports medicine sector, creating clinical value, and driving global business expansion. It will continue to improve operational quality to deliver long-term value for its shareholders and investors.